{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:09:54Z","timestamp":1791846594981,"version":"4.3.4"},"reference-count":52,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["AMR-19-ECD-2011"],"award-info":[{"award-number":["AMR-19-ECD-2011"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology , Ministry of Science and Technology","doi-asserted-by":"publisher","award":["BT\/03\/IYBA\/2010"],"award-info":[{"award-number":["BT\/03\/IYBA\/2010"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2017.00805","type":"journal-article","created":{"date-parts":[[2017,5,8]],"date-time":"2017-05-08T04:33:41Z","timestamp":1494218021000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Celecoxib Enhances the Efficacy of Low-Dose Antibiotic Treatment against Polymicrobial Sepsis in Mice and Clinical Isolates of ESKAPE Pathogens"],"prefix":"10.3389","volume":"8","author":[{"given":"Madhavi","family":"Annamanedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gajapati Y. N.","family":"Varma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Anuradha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunasree M.","family":"Kalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2017,5,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1586\/1744666X.5.2.145","article-title":"Eicosanoids in inflammation and cancer: the role of COX-2.","volume":"5","author":"Agarwal","year":"2009","journal-title":"Expert Rev. Clin. Immunol."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099285","article-title":"Celecoxib sensitizes Staphylococcus aureus to antibiotics in macrophages by modulating SIRT1.","volume":"9","author":"Annamanedi","year":"2014","journal-title":"PLoS ONE"},{"key":"B3","doi-asserted-by":"publisher","first-page":"595","DOI":"10.4049\/jimmunol.174.2.595","article-title":"Cutting edge: macrophage inhibition by cyclic AMP (cAMP): differential roles of protein kinase A and exchange protein directly activated by cAMP-1.","volume":"174","author":"Aronoff","year":"2005","journal-title":"J. Immunol."},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1186\/1476-0711-12-22","article-title":"New antibiotics for bad bugs: where are we?","volume":"12","author":"Bassetti","year":"2013","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mib.2015.05.008","article-title":"Antimicrobial interactions: mechanisms and implications for drug discovery and resistance evolution.","volume":"27","author":"Bollenbach","year":"2015","journal-title":"Curr. Opin. Microbiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/595011","article-title":"Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America.","volume":"48","author":"Boucher","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1038\/nrd4675","article-title":"Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?","volume":"14","author":"Brown","year":"2015","journal-title":"Nat. Rev. Drug Discov."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.3892\/etm.2015.2190","article-title":"Gemfibrozil attenuates the inflammatory response and protects rats from abdominal sepsis.","volume":"9","author":"Camara-Lemarroy","year":"2015","journal-title":"Exp. Ther. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta12110","article-title":"Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.","volume":"12","author":"Chen","year":"2008","journal-title":"Health Technol. Assess."},{"key":"B10","year":"2012","journal-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard\u2014"},{"key":"B11","doi-asserted-by":"publisher","first-page":"6930","DOI":"10.4049\/jimmunol.1002300","article-title":"Early enhanced local neutrophil recruitment in peritonitis-induced sepsis improves bacterial clearance and survival.","volume":"185","author":"Craciun","year":"2010","journal-title":"J. Immunol."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/0471142735.im1913s91","article-title":"Cecal ligation and puncture.","volume":"91","author":"Cuenca","year":"2010","journal-title":"Curr. Protoc. Immunol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2174\/138161213804070285","article-title":"The rise of carbapenem-resistant Acinetobacter baumannii.","volume":"19","author":"Evans","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"B14","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1086\/651094","article-title":"Excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection.","volume":"31","author":"Filice","year":"2010","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1093\/cid\/cir202","article-title":"Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention.","volume":"53","author":"Gupta","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.00788","article-title":"Global Emergence and Dissemination of Enterococci as Nosocomial Pathogens: attack of the Clones?","volume":"7","author":"Guzman Prieto","year":"2016","journal-title":"Front. Microbiol."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.01435","article-title":"Rapid Detection of K1 Hypervirulent Klebsiella pneumoniae by MALDI-TOF MS.","volume":"6","author":"Huang","year":"2015","journal-title":"Front. Microbiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1128\/AAC.00735-10","article-title":"Inhibition of bacterial multidrug resistance by celecoxib, a cyclooxygenase-2 inhibitor.","volume":"55","author":"Kalle","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.001","article-title":"Breaking the spell: combating multidrug resistant \u2018Superbugs\u2019.","volume":"7","author":"Khan","year":"2016","journal-title":"Front. Microbiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1093\/jac\/dkm347","article-title":"Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse model.","volume":"60","author":"Kokai-Kun","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"B21","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0924-8579(01)00317-X","article-title":"Antibiotic selective pressure and development of bacterial resistance.","volume":"17","author":"Kolar","year":"2001","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B22","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0140-6736(15)00474-2","article-title":"Access to effective antimicrobials: a worldwide challenge.","volume":"387","author":"Laxminarayan","year":"2015","journal-title":"Lancet"},{"key":"B23","doi-asserted-by":"publisher","first-page":"344","DOI":"10.2337\/db07-1795","article-title":"Overexpression of SIRT1 protects pancreatic beta-cells against cytokine toxicity by suppressing the nuclear factor-kappaB signaling pathway.","volume":"58","author":"Lee","year":"2009","journal-title":"Diabetes Metab. Res. Rev."},{"key":"B24","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1099\/00221287-147-1-97","article-title":"In vitro resistance of Burkholderia cepacia complex isolates to reactive oxygen species in relation to catalase and superoxide dismutase production.","author":"Lefebre","year":"2001","journal-title":"Microbiology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/S0025-7125(16)30759-3","article-title":"Imipenem: a new carbapenem antibiotic.","volume":"72","author":"Lipman","year":"1988","journal-title":"Med. Clin. North Am."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-014-0648-3","article-title":"Analysis of nucleotide-binding oligomerization domain proteins in a murine model of pneumococcal meningitis.","volume":"14","author":"Liu","year":"2014","journal-title":"BMC Infect. Dis."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.4103\/1947-2714.128482","article-title":"Western blot: technique, theory and trouble shooting.","volume":"6","author":"Liu","year":"2014","journal-title":"N. Am. J. Med. Sci."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2013.00422","article-title":"Responses of Pseudomonas aeruginosa to antimicrobials.","volume":"4","author":"Morita","year":"2014","journal-title":"Front. Microbiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1128\/IAI.01213-09","article-title":"Characterization and modulation of the immunosuppressive phase of sepsis.","volume":"78","author":"Muenzer","year":"2010","journal-title":"Infect. Immun."},{"key":"B30","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2165\/0148581-200810060-00004","article-title":"Treatment strategies for methicillin-resistant Staphylococcus aureus infections in pediatrics.","volume":"10","author":"Newland","year":"2008","journal-title":"Paediatr. Drugs"},{"key":"B31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jss.2008.04.030","article-title":"NF-kappaB and p38 MAPK inhibition improve survival in endotoxin shock and in a cecal ligation and puncture model of sepsis in combination with antibiotic therapy.","volume":"152","author":"O\u2019Sullivan","year":"2009","journal-title":"J. Surg. Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1586\/eri.13.12","article-title":"Clinical relevance of the ESKAPE pathogens.","volume":"11","author":"Pendleton","year":"2013","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"B33","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/SHK.0b013e318181a343","article-title":"Experimental models of sepsis and their clinical relevance.","author":"Poli-de-Figueiredo","year":"2008","journal-title":"Shock"},{"key":"B34","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/nrmicro2539","article-title":"Modulation of NF-kappaB signalling by microbial pathogens.","volume":"9","author":"Rahman","year":"2011","journal-title":"Nat. Rev. Microbiol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1161\/ATVBAHA.110.207449","article-title":"Prostaglandins and inflammation.","volume":"31","author":"Ricciotti","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1093\/jac\/dkl354","article-title":"Two decades of imipenem therapy.","volume":"58","author":"Rodloff","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"B37","first-page":"473","article-title":"[Antibiotic susceptibility analysis of Enterococcus spp. isolated from urine].","volume":"61","author":"Rudy","year":"2004","journal-title":"Przegl. Lek."},{"key":"B38","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1002\/bies.20799","article-title":"SIRT1 longevity factor suppresses NF-kappaB -driven immune responses: regulation of aging via NF-kappaB acetylation?","volume":"30","author":"Salminen","year":"2008","journal-title":"Bioessays"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/2475067","article-title":"Mechanisms of antimicrobial resistance in ESKAPE pathogens.","volume":"2016","author":"Santajit","year":"2016","journal-title":"Biomed. Res. Int."},{"key":"B40","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/SHK.0b013e3181f48942","article-title":"Combination of imipenem and TAK-242, a Toll-like receptor 4 signal transduction inhibitor, improves survival in a murine model of polymicrobial sepsis.","volume":"35","author":"Sha","year":"2011","journal-title":"Shock"},{"key":"B41","doi-asserted-by":"publisher","first-page":"11492","DOI":"10.1074\/jbc.M110.198713","article-title":"Resveratrol-mediated SIRT-1 interactions with p300 modulate receptor activator of NF-kappaB ligand (RANKL) activation of NF-kappaB signaling and inhibit osteoclastogenesis in bone-derived cells.","volume":"286","author":"Shakibaei","year":"2011","journal-title":"J. Biol. Chem."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.ajic.2014.06.013","article-title":"Evolution of the resistance to antibiotics of bacteria involved in urinary tract infections: a 7-year surveillance study.","volume":"42","author":"Sorlozano","year":"2014","journal-title":"Am. J. Infect. Control"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115705","article-title":"A new cecal slurry preparation protocol with improved long-term reproducibility for animal models of sepsis.","volume":"9","author":"Starr","year":"2014","journal-title":"PLoS ONE"},{"key":"B44","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.4049\/jimmunol.162.9.5437","article-title":"Multiple roles for IL-12 in a model of acute septic peritonitis.","volume":"162","author":"Steinhauser","year":"1999","journal-title":"J. Immunol."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2015.00750","article-title":"Repurposing celecoxib as a topical antimicrobial agent.","volume":"6","author":"Thangamani","year":"2015","journal-title":"Front. Microbiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2860","DOI":"10.3791\/2860","article-title":"Cecal ligation puncture procedure.","author":"Toscano","year":"2011","journal-title":"J. Vis. Exp."},{"key":"B47","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/cpt.82","article-title":"Mining drug-disease relationships as a complement to medical genetics-based drug repositioning: where a recommendation system meets GWAS.","volume":"97","author":"Wang","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0069555","article-title":"An estrogen receptor dependent mechanism of Oroxylin A in the repression of inflammatory response.","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS ONE"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005372","article-title":"HTLV-1 bZIP factor impairs anti-viral immunity by inducing co-inhibitory molecule, T cell immunoglobulin and ITIM domain (TIGIT).","volume":"12","author":"Yasuma","year":"2016","journal-title":"PLoS Pathog."},{"key":"B50","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1038\/mi.2014.104","article-title":"\u03b2-Arrestin2 encourages inflammation-induced epithelial apoptosis through ER stress\/PUMA in colitis.","volume":"8","author":"Zeng","year":"2015","journal-title":"Mucosal. Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"7097","DOI":"10.1074\/jbc.M109.038604","article-title":"SIRT1 suppresses activator protein-1 transcriptional activity and cyclooxygenase-2 expression in macrophages.","volume":"285","author":"Zhang","year":"2010","journal-title":"J. Biol. Chem."},{"key":"B52","doi-asserted-by":"publisher","first-page":"41391","DOI":"10.1074\/jbc.M110.174482","article-title":"Roles of SIRT1 in the acute and restorative phases following induction of inflammation.","volume":"285","author":"Zhang","year":"2010","journal-title":"J. Biol. Chem."}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2017.00805\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T13:00:42Z","timestamp":1692795642000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fmicb.2017.00805\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,8]]},"references-count":52,"alternative-id":["10.3389\/fmicb.2017.00805"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2017.00805","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,8]]},"article-number":"805"}}